Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | |||
| neonatal_conjunctivitis [2026/02/16 21:26] – Scott Larson | neonatal_conjunctivitis [2026/02/16 21:27] (current) – [Treatment] Scott Larson | ||
|---|---|---|---|
| Line 48: | Line 48: | ||
| * Coinfection with the above two is common so combined treatment should be considered | * Coinfection with the above two is common so combined treatment should be considered | ||
| * Other bacteria: consider moxifloxicin TID or QID x 10 days guided by culture with close follow-up | * Other bacteria: consider moxifloxicin TID or QID x 10 days guided by culture with close follow-up | ||
| - | * Viral- consider [[acyclovir|antiviral treatment]] for HSV infection. | + | * Viral- consider [[acyclovir|antiviral treatment]] for suspected |